dm+d

Unassigned

New Medicines

Mosaic HIV infection - prophylaxis in healthy individuals

Information

Mosaic
Vaccine
Janssen Vaccines and Prevention BV
Janssen Vaccines and Prevention BV

Development and Regulatory status

None
Phase III Clinical Trials
Phase III Clinical Trials

Category

Recombinant live attenuated HIV virus-vectored HIV vaccine for the prevention of HIV infections - for use in combination with Janssens Ad26.ENVA.01 vaccine
The number of HIV-negative people attending sexual health clinics was 116,657 in 2015 – with an additional 10,000 expected annually thereafter. [8]
HIV infection - prophylaxis in healthy individuals
Intramuscular